NEW YORK (Reuters Health) – Administering acetylcysteine to patients before and after they undergo coronary or peripheral angiography does not reduce the occurrence of contrast-induced nephropathy, according to…
NEW YORK (Reuters Health) – Repairing vaginal prolapse with polypropylene mesh may cause more problems than it solves, according to results of a double-blind randomized study. In the…
NEW YORK (Reuters Health) – New data from phase III randomized clinical trials have prompted a focused update of one recommendation contained in the 2009 American Society of…
NEW YORK (Reuters Health) – Children with cystic fibrosis and recently acquired Pseudomonas aeruginosa infection fare as well with either cycled or culture-based tobramycin inhalation therapy, results of…
NEW YORK (Reuters Health) – An analysis of epidemiologic data confirms that the incidence of second primary malignancies is increased after external beam radiotherapy (EBRT) for stage I…
NEW YORK (Reuters Health) – The high risk of fractures in the first year after solid organ transplantation can be roughly halved with bisphosphonate or vitamin D treatment,…
NEW YORK (Reuters Health) – Delivery of the antispasmodic, antimuscarinic agent oxybutynin in a topical gel relieves urinary symptoms and improves health-related quality of life in women with…
NEW YORK (Reuters Health) – Despite having a favorable effect on cytokine levels, perioperative methylprednisolone does not reduce the incidence of lung injury after pulmonary thromboendarterectomy (PTE), according…
NEW YORK (Reuters Health) – In patients with acute coronary syndrome undergoing percutaneous coronary intervention (PCI) prasugrel shows the most favorable benefit-to-risk ratio in the core group of…
NEW YORK (Reuters Health) – In low-risk women, exercise treadmill testing (ETT) gives similar results to exercise myocardial perfusion imaging (MPI) and is less expensive, researchers report in…
